Clinical trial
An Open-Label Randomized Pilot Study of Safety and Preliminary Efficacy of TG100801 in Patients With Choroidal Neovascularization Due to Age-Related Macular Degeneration
NCT00509548 is registered in ClinicalTrials.gov with TargeGen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Randomized Pilot Study of Safety and Preliminary Efficacy of TG100801 in Patients With Choroidal Neovascularization Due to Age-Related Macular Degeneration
- Lead sponsor
- TargeGen
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 31, 2007
- Completion date
- March 31, 2008
- Enrollment
- 7 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.